Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE.

Cell Stem Cell. 2009 Jul 2;5(1):111-23. doi: 10.1016/j.stem.2009.06.008.

2.

Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.

Bai Q, Desprat R, Klein B, LemaƮtre JM, De Vos J.

Curr Gene Ther. 2013 Apr;13(2):93-8. Review.

3.

Evolution of induced pluripotent stem cell technology.

Zhou H, Ding S.

Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Review.

PMID:
20442654
4.

Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Rebuzzini P, Zuccotti M, Redi CA, Garagna S.

Cell Mol Life Sci. 2016 Jul;73(13):2453-66. doi: 10.1007/s00018-016-2171-8. Review.

PMID:
26961132
5.

From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.

Galach M, Utikal J.

Exp Dermatol. 2011 Jun;20(6):523-8. doi: 10.1111/j.1600-0625.2011.01282.x. Review.

PMID:
21585557
6.

microRNA control of mouse and human pluripotent stem cell behavior.

Greve TS, Judson RL, Blelloch R.

Annu Rev Cell Dev Biol. 2013;29:213-39. doi: 10.1146/annurev-cellbio-101512-122343. Review.

7.

[Pluripotent stem cells: maintenance of genetic and epigenetic stability and prospects of cell technologies].

Gordeeva OF, Mitalipov ShM.

Ontogenez. 2008 Nov-Dec;39(6):405-19. Review. Russian.

PMID:
19137706
8.

[Research on MicroRNAs in pluripotent stem cells].

Wang CY, Yang SH.

Dongwuxue Yanjiu. 2012 Aug;33(4):416-20. Review. Chinese.

9.
10.

From "ES-like" cells to induced pluripotent stem cells: a historical perspective in domestic animals.

Koh S, Piedrahita JA.

Theriogenology. 2014 Jan 1;81(1):103-11. doi: 10.1016/j.theriogenology.2013.09.009. Review.

11.

DNA methylation dynamics in human induced pluripotent stem cells.

Nishino K, Umezawa A.

Hum Cell. 2016 Jul;29(3):97-100. doi: 10.1007/s13577-016-0139-5. Review.

PMID:
27083573
12.

Investigating monogenic and complex diseases with pluripotent stem cells.

Zhu H, Lensch MW, Cahan P, Daley GQ.

Nat Rev Genet. 2011 Apr;12(4):266-75. doi: 10.1038/nrg2951. Review.

PMID:
21386866
13.

Pluripotent stem cells: immune to the immune system?

Pearl JI, Kean LS, Davis MM, Wu JC.

Sci Transl Med. 2012 Dec 12;4(164):164ps25. doi: 10.1126/scitranslmed.3005090. Review.

14.

DNA double-strand break response in stem cells: mechanisms to maintain genomic integrity.

Nagaria P, Robert C, Rassool FV.

Biochim Biophys Acta. 2013 Feb;1830(2):2345-53. doi: 10.1016/j.bbagen.2012.09.001. Review.

PMID:
22995214
15.

Gene targeting in human pluripotent cells.

Hockemeyer D, Jaenisch R.

Cold Spring Harb Symp Quant Biol. 2010;75:201-9. doi: 10.1101/sqb.2010.75.021. Review.

PMID:
21209393
16.

Genomic instability in pluripotent stem cells: implications for clinical applications.

Peterson SE, Loring JF.

J Biol Chem. 2014 Feb 21;289(8):4578-84. doi: 10.1074/jbc.R113.516419. Review.

Items per page

Supplemental Content

Support Center